Eric Mou

Also affiliated with University of Iowa Hospitals and Clinics

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma”.

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma

Blood(2020)10.1182/blood.2020007400

N/A

4.5DataRank · unranked

141 citations

Hatice Savas, Andrew M. Evens, Ranjana H. Advani, Brett Alan Palmer, Barbara Pro +11 more

Molecular techniques drive cutting edge advancements in management of cutaneous T cell lymphoma

Frontiers in Immunology(2023)10.3389/fimmu.2023.1228563

N/A

0DataRank · unranked

6 citations

Nicholas Borcherding, Ryan J. Reis, Eric Mou, Vincent Liu, Ali Jabbari +1 more

126 | THE EARLY‐STAGE CLASSIC HODGKIN LYMPHOMA INTERNATIONAL PROGNOSTICATION INDEX (E‐HIPI): AN INDIVIDUALIZED PREDICTION MODEL UTILIZING OBJECTIVE AND CONTINUOUS VARIABLES

Hematological Oncology(2025)10.1002/hon.70093_126

N/A

0DataRank · unranked

0 citations

Angie May Rodday, Matthew J. Maurer, Jenica Upshaw, Nicholas Counsell, Sabrina Rossetti +19 more

29 | A COMPARATIVE ANALYSIS OF HISTOLOGIC TRANSFORMATION OF FOLLICULAR LYMPHOMA AT DIAGNOSIS (COMPOSITE LYMPHOMA) AND SEQUENTIALLY TRANSFORMED FOLLICULAR LYMPHOMA

Hematological Oncology(2025)10.1002/hon.70093_29

N/A

0DataRank · unranked

0 citations

Melissa C. Larson, Jonathan Day, Urshila Durani, Mazie Tsang, Dai Chihara +22 more